Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Two-dimensional Gel Electrophoresis01:22

Two-dimensional Gel Electrophoresis

8.3K
Two-dimensional gel electrophoresis is a high-resolution protein separation method first introduced by O' Farrell and Klose in 1975. This method involves protein separation by two dimensions, mass and charge, making it more accurate than one-dimensional gel electrophoresis.
The first dimension separation uses the isoelectric focusing or IEF technique performed on immobilized pH gradient (IPG) strips that separate proteins according to their isoelectric points.
Biological samples, such...
8.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Enactive Torch: Open-source sensory substitution device for neurophysiological research.

HardwareX·2026
Same author

Quantitative Host Cell Protein Analysis of Antibody-Based Protein Therapeutics Using the Orbitrap Astral Mass Spectrometer.

Journal of the American Society for Mass Spectrometry·2026
Same author

Native Top-Down Mass Spectrometry Combined with High-Resolution Charge Variant Analysis of Trastuzumab Originator and Biosimilars.

Journal of the American Society for Mass Spectrometry·2026
Same author

Placenta Percreta Treated by Uterine Artery Embolization, with Fatal Outcome: A Case Report.

Journal of vascular and interventional radiology : JVIR·2026
Same author

The role of parental consent: Implications for surveying minors who experience or are at risk for commercial sexual exploitation in the United States.

Social science & medicine (1982)·2026
Same author

Investigation into Clearance of Organic Compounds from Biomanufacturing Process Streams during Ultrafiltration/Diafiltration.

Pharmaceutical research·2026

Related Experiment Video

Updated: Apr 5, 2026

An HS-MRM Assay for the Quantification of Host-cell Proteins in Protein Biopharmaceuticals by Liquid Chromatography Ion Mobility QTOF Mass Spectrometry
11:09

An HS-MRM Assay for the Quantification of Host-cell Proteins in Protein Biopharmaceuticals by Liquid Chromatography Ion Mobility QTOF Mass Spectrometry

Published on: April 17, 2018

10.7K

Quantitative host cell protein analysis using two dimensional data independent LC-MS(E).

Amy Farrell1,2, Stefan Mittermayr1, Brian Morrissey1

  • 1Characterisation and Comparability Laboratory, NIBRT-The National Institute for Bioprocessing Research and Training , Foster Avenue, Mount Merrion, Blackrock, Co., Dublin, Ireland.

Analytical Chemistry
|August 18, 2015
PubMed
Summary

Host cell proteins (HCPs) are impurities in biotherapeutics. Mass spectrometry effectively identifies and quantifies HCPs, guiding purification strategies to minimize patient risk and ensure therapeutic protein safety.

More Related Videos

Author Spotlight: Detecting Low-Abundant Host Cell Proteins in Drug Products Using Enrichment Beads and Limited Digestion
09:45

Author Spotlight: Detecting Low-Abundant Host Cell Proteins in Drug Products Using Enrichment Beads and Limited Digestion

Published on: January 19, 2024

3.0K
Resolving Affinity Purified Protein Complexes by Blue Native PAGE and Protein Correlation Profiling
09:35

Resolving Affinity Purified Protein Complexes by Blue Native PAGE and Protein Correlation Profiling

Published on: April 1, 2017

14.7K

Related Experiment Videos

Last Updated: Apr 5, 2026

An HS-MRM Assay for the Quantification of Host-cell Proteins in Protein Biopharmaceuticals by Liquid Chromatography Ion Mobility QTOF Mass Spectrometry
11:09

An HS-MRM Assay for the Quantification of Host-cell Proteins in Protein Biopharmaceuticals by Liquid Chromatography Ion Mobility QTOF Mass Spectrometry

Published on: April 17, 2018

10.7K
Author Spotlight: Detecting Low-Abundant Host Cell Proteins in Drug Products Using Enrichment Beads and Limited Digestion
09:45

Author Spotlight: Detecting Low-Abundant Host Cell Proteins in Drug Products Using Enrichment Beads and Limited Digestion

Published on: January 19, 2024

3.0K
Resolving Affinity Purified Protein Complexes by Blue Native PAGE and Protein Correlation Profiling
09:35

Resolving Affinity Purified Protein Complexes by Blue Native PAGE and Protein Correlation Profiling

Published on: April 1, 2017

14.7K

Area of Science:

  • Biopharmaceutical Manufacturing
  • Proteomics
  • Analytical Chemistry

Background:

  • Host cell proteins (HCPs) are critical impurities in recombinant protein production, necessitating robust removal strategies.
  • Traditional anti-HCP ELISA methods offer limited characterization, prompting the need for advanced analytical techniques.
  • Ensuring patient safety requires thorough assessment and control of HCPs in therapeutic proteins.

Purpose of the Study:

  • To characterize Host cell protein (HCP) repertoires in monoclonal antibody (mAb) samples using advanced mass spectrometry.
  • To evaluate the impact of downstream purification (DSP) parameters, including harvest time and elution buffers, on HCP levels.
  • To assess the effect of purification strategies on critical quality attributes (CQAs) of therapeutic mAbs.

Main Methods:

  • Application of a 2D-LC-MS(E) proteomic platform for high-resolution HCP profiling.
  • Analysis of HCPs in Protein A purified mAb samples across different harvest times and elution buffers.
  • Evaluation of CQAs for mAbs purified using various Protein A elution buffers.

Main Results:

  • An arginine-based Protein A elution buffer significantly minimized identified and quantified HCP levels in purified mAb samples.
  • Later harvest times correlated with higher HCP concentrations, which were effectively reduced by complementary DSP steps.
  • Purification strategies employing specific elution buffers and DSP steps did not adversely affect mAb product CQAs.

Conclusions:

  • Mass spectrometry-based HCP determination provides valuable insights for optimizing purification processes.
  • Strategic selection of Protein A elution buffers and downstream purification steps is crucial for minimizing HCPs in therapeutic mAbs.
  • Optimized bioprocessing parameters, guided by mass spectrometry, enhance the safety and efficacy of therapeutic proteins by reducing HCP burden.